Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses

Study ID: NCT06541795
Start Date: 2025-06
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

210

Intervention / Treatment

AcrySof IQ Vivity Extended Vision IOL

Sponsor

Alcon Research

Source: clinicaltrials.gov

Share:
Add to list

Hyperkalemia Quality Improvement Program (HK-QIP) Study

Study ID: NCT06884267
Start Date: 2025-05-21
End Date: 2027-12-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

standard hyperkalemia management implementation

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Corneal Topography in Vernal Keratoconjunctivitis

Study ID: NCT06746467
Start Date: 2025-06
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

44

Intervention / Treatment

pentacam

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease

Study ID: NCT06885567
Start Date: 2025-07
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

BEY2153

Placebo

Sponsor

BeyondBio Inc.

Source: clinicaltrials.gov

Share:
Add to list

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Study ID: NCT06138067
Start Date: 2025-05-06
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

High intensity approach

Low intensity approach

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation

Study ID: NCT06732440
Start Date: 2025-07-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Subthreshold Vestibular Conditioning

Balance Training

Sponsor

Creighton University

Source: clinicaltrials.gov

Share:
Add to list

A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury

Study ID: NCT06870240
Start Date: 2025-06-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Neurosteroid enantiomer

Sponsor

Oragenics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Obesity and Oral Diseases in Adult Patients

Study ID: NCT04602572
Start Date: 2025-09-01
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Lifestyle course.

Bariatric surgery.

Sponsor

University of Bergen

Source: clinicaltrials.gov

Share:
Add to list

Association Between Serum and Neuroimaging Measurements of the GABAergic System

Study ID: NCT06464172
Start Date: 2025-05-05
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Acute Oral gamma-aminobutyric acid (Natural Health Product in Canada)

Acute Placebo

Sponsor

Francois Corbin

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Study ID: NCT06863272
Start Date: 2025-06-17
End Date: 2030-02-18
Study Type

Interventional

Study Phase

Phase2

No. of Participants

360

Intervention / Treatment

Docetaxel

Ifinatamab deruxtecan

MK-5684

Abiraterone

Enzalutamid

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list